A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
Phase 2
Completed
- Conditions
- Cognition DisordersMultiple Sclerosis
- First Posted Date
- 2007-09-14
- Last Posted Date
- 2008-05-28
- Lead Sponsor
- Cognition Pharmaceuticals, LLC
- Target Recruit Count
- 150
- Registration Number
- NCT00529581
- Locations
- 🇺🇸
Shepard Center, Atlanta, Georgia, United States
🇺🇸Riverhills Healthcare, Inc, Cincinnati, Ohio, United States
🇺🇸Integra Clinical Research, San Antonio, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath